易特科(前海安测)中标北京“AI+慢病”

2020-03-19 15:49

2020年3月19日消息,易特科(前海安测)华北市场传来捷报,拥有自主知识产权的安测“AI+慢病”项目于近日成功中标北京市某医院。该项目将通过搭建慢病管理平台,依托智能健康一体机,软硬件高度结合,数据互联互通,为该医院提供全流程、全方位产品服务和技术方案支持,为该院慢病患者提供一站式慢病管理创新服务。


安测慢病管理创新服务,不仅可以优化医院的慢病管理流程,提高医生问诊效率,同时还能实现对慢病患者病情的实时监测、全程管理,更好满足所辖居民家庭医生签约和健康管理服务,提升患者就医体验。此次中标,是易特科(前海安测)“AI+慢病管理”创新服务在慢病管理领域又一突破,为拓展华北市场,打造样板示范点奠定了扎实基础,同时也再次证明了易特科(前海安测)自主研发的AI慢病管理系统在行业内雄厚的市场竞争力和良好的品牌口碑。

易特科集团(前海安测)是一家专业从事生命IT技术研究和产品开发的高新技术企业。2003年创立以来,易特科集团深耕医疗大健康行业,以尖端技术研究和创新为公司核心发展战略,持续投入信息技术、生物科技、数字技术等领域,以最先进的人工智能、大数据、深度学习等技术和产品服务于医疗信息化、健康养老行业,致力于通过生命科学与信息科学融合创新,提升临床医学的效率、效力和效益。

易特科集团总部位于深圳南山科技园数字技术园,在北京、上海、广州、天津、西安、石家庄、福州、沈阳、长沙、桂林等地设有分部,并在美国硅谷、欧洲爱尔兰和芬兰和中国香港等地设有海外分支机构。目前,医疗智能化、智能检测设备、医疗信息化、健康信息化、区域卫生信息化等产品和解决方案入选国家工信部产品服务推广目录,并广泛应用于全国650多家三甲医院、二甲医院以及450家社康中心和健康管理中心,得到了市场的积极响应和广泛好评。

多年来,易特科集团一直秉承"创新驱动·技术引领"的经营理念,与国内外众多知名高校、研究机构、知名企业和科学家团队建立了广泛的合作关系,在智慧医疗和健康养老领域持续创新和产业化应用。公司拥有院士工作站、博士后工作站、博士工作站;核心科学家包括中外院士、教授、博士和研发人员200余名。易特科集团已经与清华大学签署战略合作协议,双方将在智慧医疗创新开展战略合作;同时成为华为全球生态合作伙伴(严选方案、鲲鹏云ARM架构、ISV)。

目前,易特科集团在“AI+医疗+健康+养老”领域已申请/拥有各类知识产权3100多项,是国家、广东省和深圳市知识产权优势企业、广东省知识产权示范企业,并获得六项中国专利优秀奖,在智慧医疗细分领域专利申请数量国内第一、世界第四,四家子公司入选2018中国企业PCT国际专利申请排行榜TOP100。

易特科集团已获得II类医疗器械注册和生产许可证(NMPA/GMP认证)、III类医疗器械经营许可证(经营GSP认证);是国家高新技术企业、国家工信部智慧健康养老应用试点示范企业、国家工信部医疗大数据产业发展试点示范企业、智慧健康养老产品及服务推广目录企业、广东省健康管理互联网工程技术研究中心、广东省慢性病大数据工程技术研究中心,并获得深圳市科技进步二等奖、深圳市创新企业70强、深圳市质量百强企业等荣誉。此外,凭借在生命IT、大健康和互联网医疗领域的杰出贡献,易特科集团董事长兼CEO张贯京先生获评中国智慧医疗行业领军人物、中国智慧医疗行业诚信企业家功勋奖、广东省特支计划科技创业领军人才等荣誉。

未来,易特科集团将以持续的创新能力、深厚的技术积累和优质的客户服务,打造“独角兽”硬科技高新技术企业,快速迈进IPO。

E-Techco (Qianhai AnyCheck) Won the Bid for Beijing's "AI + Chronic Disease"

News on March 19, 2020, E-Techco (Qianhai AnyCheck) North China market received a good new, and the AnyCheck “AI + chronic disease” project with independent intellectual property rights has recently won a bid for a hospital in Beijing. The project is mainly to build a chronic disease management platform for the hospital. Relying on an intelligent health all-in-one machine, a high degree of integration of software and hardware, and data interconnection, this project will provide the hospital with a full process, comprehensive product services and technical solution support, and provide one-stop chronic disease management innovative services for the patients with chronic diseases in the hospital.

AnyCheck innovative services for chronic disease management can not only optimize the hospital's chronic disease management process and improve the efficiency of doctors' consultations, but also realize the real-time monitoring and full-course management for the condition of patients with chronic disease. Meanwhile, our chronic disease management service can better meet the family doctor contracting and health management services of residents under their jurisdiction, and improve the patient's medical experience. The successful bid is another breakthrough for E-Techco (Qianhai AnyCheck) 's "AI + chronic disease management" innovation service in the field of chronic disease management, which lays a solid foundation for expanding the North China market and creating a model demonstration point. It also proves that E-Techco (Qianhai AnyCheck) independently developed AI chronic disease management system has strong market competitiveness and good brand reputation in the industry.

E-Techco Group (Qianhai AnyCheck) is a high-tech enterprise in life IT technology research and product development. Since its establishment in 2003, E-Techco has been deeply rooted in the medical health industry, with cutting-edge technology research and innovation as its core development strategy, focusing on corporate culture and brand building, and continuing to invest in information technology, biotechnology, digital technology and other fields. It uses the most advanced AI, big data, deep learning and other technologies and products to serve medical informationization and health care industry. It is committed to improving the efficiency, effectiveness and efficiency of clinical medicine through the integration and innovation of life science and information science.

E-Techco Group is located in Shenzhen Nanshan S&T Park Digital Technology Park, with branches in Beijing, Shanghai, Guangzhou, Tianjin, Xi'an, Shijiazhuang, Fuzhou, Shenyang, Changsha and Guilin. And overseas branches are in Hong Kong, Silicon Valley, Europe, Ireland and Finland, etc. At present, products and solutions of company such as medical intelligence, intelligent testing equipment, medical informationatization, health informationatization, and regional health informationatization have been selected into the catalogue of promoted product from the Ministry of Industry and Information Technology of China, and are widely used in more than 650 top three hospitals, 450 social health centers and health management centers. The products have received positive response and wide acclaim from the market.

Over the years, E-Techco has been adhering to the business philosophy of“Innovation-driven and technology-led”, and has established extensive cooperative relationships with many well-known universities, research institutes, famous enterprises and scientists at home and abroad, and continues to innovate and industrialize in the fields of smart medical care and healthy retirement. application. At present, there are academician workstations, postdoctoral workstations, and doctoral workstations; core scientists include Chinese and foreign academicians,  professors, doctors, and more than 200 research and development personnel. E-Techco has signed a strategic cooperation agreement with Tsinghua University. The two sides have carried out strategic cooperation in joint talent training and R&D innovation in smart medical field. At the same time, Qianhai AnyCheck have become Huawei's ecological partners (Strictly selected program, Kunpengyun ARM architecture, ISV).

At present, E-Techco has applied/owned over 3,100 kinds of intellectual property rights in the field of “AI+ Medical+ Health+ Elderly Care”. It has honored Intellectual Property Advantage Enterprise of China, Guangdong Province and Shenzhen. It also has achieved demonstration enterprise of intellectual property rights of Guangdong Province. Besides, it achieved four China Patent Excellence Awards, and the number of patent applications in the field of smart medical segment ranked first in the country and fourth in the world. Four subsidiaries of group are selected as TOP100 in the PCT international patent application list of 2018 Chinese enterprises.

E-Techco Group has obtained Class II medical device registration and production license (NMPA/GMP certification) and Class III medical device business license (GSP certification). It is a national high-tech enterprise, National Ministry of Industry and Information Technology Smart Health Care Application Pilot Enterprise, National Ministry of Industry and Information Technology Medical Big Data Industry Development Pilot Demonstration Enterprise, Smart Health Elderly Care Products and Service Promotion Catalogue Enterprise, Guangdong Province Health Management Internet Engineering Technology Research Center, Guangdong Chronic Disease Big Data Engineering Technology Research Center, and won the second prize of Shenzhen Science and Technology Progress Awards, Shenzhen Top 70 Innovative Enterprise, Shenzhen Top 100 Quality Enterprise.

In addition, with outstanding contributions in life IT, health and Internet medical, Mr. Zhang Guanjing, Chairman and CEO of E-Techco Group, was awarded the 2018 China Smart Healthcare Industry Leader, China Smart Healthcare Industry Honest Entrepreneur Meritorious Award, Guangdong Province Special Honoring the talents of planning, technology, entrepreneurship and leading talents.

In the future, E-Techco will build an “unicorn” hard technology high-tech enterprise with continuous innovation capability, deep technical accumulation and high-quality customer service, and is preparing for the process of IPO.